GeoVax Labs, Inc.
Clinical-stage biotech developing vaccines and therapies for infectious diseases and cancer.
GOVX | US
Overview
Corporate Details
- ISIN(s):
- US3736786068
- LEI:
- Country:
- United States of America
- Address:
- 1900 LAKE PARK DRIVE, 30080 SMYRNA
- Website:
- https://www.geovax.com/
Description
GeoVax Labs, Inc. is a clinical-stage biotechnology company that develops human vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms. The company's lead oncology program is Gedeptin®, a therapy for advanced head and neck cancers which has completed enrollment in a Phase 1/2 clinical trial. Its primary infectious disease candidate is GEO-CM04S1, a next-generation COVID-19 vaccine being evaluated in Phase 2 clinical trials for high-risk, immunocompromised populations and as a heterologous booster. GeoVax's development pipeline also includes research programs for preventive vaccines against Mpox, smallpox, hemorrhagic fever viruses such as Ebola and Marburg, malaria, and Zika virus, alongside therapies for various solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-19 19:05 |
GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Us…
|
English | 15.0 KB | ||
| 2025-12-18 15:04 |
GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal Phase 3 Immunob…
|
English | 12.8 KB | ||
| 2025-12-17 15:04 |
GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobr…
|
English | 12.7 KB | ||
| 2025-12-16 15:04 |
GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID…
|
English | 11.8 KB | ||
| 2025-12-15 15:05 |
GeoVax Announces British Journal of Haematology Publication Highlighting Superi…
|
English | 15.9 KB | ||
| 2025-11-26 22:05 |
FORM 8-K
|
English | 59.1 KB | ||
| 2025-11-13 23:20 |
FORM 8-K
|
English | 120.8 KB | ||
| 2025-11-13 23:19 |
FORM 424B3
|
English | 80.1 KB | ||
| 2025-11-13 23:18 |
FORM 424B3
|
English | 80.0 KB | ||
| 2025-11-13 23:17 |
FORM 424B3
|
English | 80.0 KB | ||
| 2025-11-13 23:16 |
FORM 424B3
|
English | 80.0 KB | ||
| 2025-11-13 22:03 |
FORM 10-Q
|
English | 938.1 KB | ||
| 2025-11-07 23:24 | English | 9.7 KB | |||
| 2025-11-07 22:43 |
FORM 424B3
|
English | 506.6 KB | ||
| 2025-10-20 15:11 |
FORM 4
|
English | 6.4 KB |
Automate Your Workflow. Get a real-time feed of all GeoVax Labs, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GeoVax Labs, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GeoVax Labs, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
